Mesothelioma Types

Pleural Mesothelioma

Peritoneal Mesothelioma





Mesothelioma glossary

Asbestos Imports
mesothelioma journal articles


Mesothelioma Introduction

Mesothelioma, also known as Malignant Mesothelioma, is a rare form of cancer. Cancer cells found in the sac lining of the chest cause pleural mesothelioma and cancer cells found in the abdomen cause peritoneal mesothelioma. Most people with mesothelioma have worked on jobs where they inhaled asbestos. Workers exposed to asbestos in the 1940's, 50's, 60's and 70's, through no fault of their own, are now getting these diseases due to the long latency period of asbestos disease. The purpose of this site is to assist and empower people who have been diagnosed with mesothelioma. It is important that patients and their families understand their options in coping with mesothelioma to make an educated decision. A glossary of mesothelioma-related terms is included.

MESOTHELIOMA MEDICAL JOURNAL ARTICLES

  1. Asbestos-Induced Peritoneal Mesothelioma in a Construction Worker


  2. Current surgical management of malignant pleural mesothelioma


  3. The Role Of Imaging In Malignant Pleural Mesothelioma


  4. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma


  5. Prospective trial for the treatment of malignant peritoneal mesothelioma
  6. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE)


  7. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma



  8. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma

  9. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.


  10. Pathogenesis of malignant pleural mesothelioma.


  11. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure.

  12. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.

  13. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.


  14. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma

    15.  

    Development in the treatment of malignant mesothelioma.

To receive a FREE information packet, please fill out the following form (U.S. only please):

Name:
Phone Number:
E-mail:
Street Address:
City, State, Zip:
Comments or
Questions:
**(Packet includes information on treatment, clinical trials, cancer links, how to access legal and financial resources, and frequently asked legal questions with answers provided by The David Law Firm, P.C.). By filling out the above form you consent to being contacted by The David Law Firm regarding potentially retaining legal services.

This website is sponsored by Jonathan David* of The David Law Firm. The David Law Firm is located in The Woodlands, Texas (Greater Houston Area) and can be reached toll free at 1-800-998-9729 for more information on mesothelioma. Jonathan David is not a medical doctor. The information on these pages is for the education of mesothelioma patients and their families regarding potential medical and legal options. Patients are advised to consult with a medical doctor.

*  Licensed by the Supreme Court  of Texas.
| Pleural Mesothelioma | Peritoneal Mesothelioma | Home | Pathogenesis | Genetic susceptibility and asbestos exposure | Asbestos Imports |